Maitake mushroom extract tested as immune booster for cancer patients

NCT ID NCT06323473

Recruiting now Disease control Sponsor: The Canadian College of Naturopathic Medicine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 2 trial is testing whether a liquid extract from maitake mushrooms can improve immune function in 40 adults receiving chemotherapy or CDK4/6 inhibitors for cancer. Participants take the supplement alongside their standard treatment. The study measures changes in white blood cell counts and rates of fever-related low white blood cell counts.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Maitake mushroom extract (Black Maitake Prothera)
What this could lead to: If it works, this could point toward a natural supplement to help support the immune system during cancer treatment.
What could go wrong: This is a small, early-phase trial with no placebo group, so results may not be conclusive. Maitake could interact with other medications or cause allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Canadian College of Naturopathic Medicine - Integrative Cancer Centre
RECRUITING

Toronto, Ontario, M2K 1E2, Canada
The Centre for Health Innovation
RECRUITING

Ottawa, Ontario, K2P 0M7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.